290 related articles for article (PubMed ID: 19951255)
1. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.
Wang Z; Li Y; Sarkar FH
Curr Stem Cell Res Ther; 2010 Mar; 5(1):74-80. PubMed ID: 19951255
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
[TBL] [Abstract][Full Text] [Related]
3. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.
Bao B; Azmi AS; Li Y; Ahmad A; Ali S; Banerjee S; Kong D; Sarkar FH
Curr Stem Cell Res Ther; 2014 Jan; 9(1):22-35. PubMed ID: 23957937
[TBL] [Abstract][Full Text] [Related]
4. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness.
Wang Z; Li Y; Kong D; Sarkar FH
Curr Drug Targets; 2010 Jun; 11(6):745-51. PubMed ID: 20041844
[TBL] [Abstract][Full Text] [Related]
5. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
6. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
[TBL] [Abstract][Full Text] [Related]
7. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
8. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
Hollier BG; Evans K; Mani SA
J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):29-43. PubMed ID: 19242781
[TBL] [Abstract][Full Text] [Related]
9. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
10. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Kim HM; Haraguchi N; Ishii H; Ohkuma M; Okano M; Mimori K; Eguchi H; Yamamoto H; Nagano H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S539-48. PubMed ID: 21879266
[TBL] [Abstract][Full Text] [Related]
11. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
12. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
13. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
Nantajit D; Lin D; Li JJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
[TBL] [Abstract][Full Text] [Related]
14. The signaling mechanism of ROS in tumor progression.
Wu WS
Cancer Metastasis Rev; 2006 Dec; 25(4):695-705. PubMed ID: 17160708
[TBL] [Abstract][Full Text] [Related]
15. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells.
Zhang LN; Kong CF; Zhao D; Cong XL; Wang SS; Ma L; Huang YH
J Cell Physiol; 2019 Apr; 234(4):3570-3582. PubMed ID: 30417342
[TBL] [Abstract][Full Text] [Related]
16. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
17. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
18. Tumor and its microenvironment: a synergistic interplay.
Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition in breast cancer progression and metastasis.
Wang Y; Zhou BP
Chin J Cancer; 2011 Sep; 30(9):603-11. PubMed ID: 21880181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]